Healthcare -
Biotechnology - NASDAQ - US
$ 13.719
3.54 %
$ 199 M
Market Cap
0.11
P/E
INBX - OPERATING EXPENSES
Operating Expenses INBX - Inhibrx Biosciences, Inc.
220 M
LAST VALUE
62.07%
2 YEAR CAGR
42.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR